I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 22% ± 4% | |
| regulatory T cell | 3 studies | 16% ± 0% | |
| macrophage | 3 studies | 21% ± 0% | |
| dendritic cell | 3 studies | 24% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 22% ± 4% | |
| regulatory T cell | 3 studies | 16% ± 0% | |
| macrophage | 3 studies | 21% ± 0% | |
| dendritic cell | 3 studies | 24% ± 3% |
Insufficient scRNA-seq data for expression of AKIP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1197.62 | 1445 / 1445 | 100% | 17.47 | 183 / 183 |
| stomach | 100% | 730.77 | 359 / 359 | 100% | 20.38 | 286 / 286 |
| brain | 100% | 1000.79 | 2641 / 2642 | 100% | 36.14 | 705 / 705 |
| kidney | 100% | 1023.36 | 89 / 89 | 100% | 24.72 | 900 / 901 |
| thymus | 100% | 1094.82 | 653 / 653 | 100% | 36.14 | 604 / 605 |
| lung | 100% | 961.75 | 577 / 578 | 100% | 26.30 | 1154 / 1155 |
| adrenal gland | 100% | 1700.83 | 258 / 258 | 100% | 26.32 | 229 / 230 |
| uterus | 100% | 1227.32 | 170 / 170 | 100% | 33.59 | 457 / 459 |
| skin | 100% | 809.58 | 1803 / 1809 | 100% | 30.27 | 471 / 472 |
| intestine | 100% | 993.75 | 966 / 966 | 99% | 23.29 | 524 / 527 |
| ovary | 100% | 1020.87 | 180 / 180 | 99% | 15.08 | 427 / 430 |
| prostate | 100% | 1009.80 | 245 / 245 | 99% | 17.95 | 498 / 502 |
| breast | 100% | 820.93 | 459 / 459 | 99% | 24.45 | 1109 / 1118 |
| bladder | 100% | 1014.38 | 21 / 21 | 99% | 26.16 | 499 / 504 |
| liver | 99% | 433.00 | 223 / 226 | 100% | 19.77 | 404 / 406 |
| pancreas | 96% | 392.81 | 316 / 328 | 99% | 22.83 | 177 / 178 |
| adipose | 100% | 811.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 21.96 | 80 / 80 |
| spleen | 100% | 1400.10 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 35.38 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.88 | 1 / 1 |
| blood vessel | 100% | 1213.45 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 791.78 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 878.72 | 852 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 16.81 | 28 / 29 |
| peripheral blood | 61% | 355.36 | 564 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1901222 | Biological process | regulation of non-canonical NF-kappaB signal transduction |
| GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | AKIP1 |
| Protein name | A-kinase interacting protein 1 A-kinase-interacting protein 1 (Breast cancer-associated gene 3 protein) (PKA-interacting protein) (Proline-rich protein BCA3) A-kinase interacting protein 1 (cDNA FLJ55419, highly similar to Proline-rich protein BCA3) |
| Synonyms | BCA3 C11orf17 |
| Description | FUNCTION: Enhances NF-kappa-B transcriptional activity by regulating the nuclear localization of the NF-kappa-B subunit RELA and promoting the phosphorylation of RELA by PRKACA. Regulates the effect of the cAMP-dependent protein kinase signaling pathway on the NF-kappa-B activation cascade. . |
| Accessions | ENST00000309377.9 [Q9NQ31-1] B4DGE2 ENST00000529942.1 ENST00000534506.5 ENST00000529876.5 ENST00000525005.5 E9PPN7 H0YCH8 ENST00000524577.5 ENST00000396648.6 [Q9NQ31-3] Q9NQ31 ENST00000309357.8 [Q9NQ31-2] E9PNI1 ENST00000530281.5 E9PN38 ENST00000299576.9 [Q9NQ31-3] ENST00000534147.5 [Q9NQ31-1] |
